Johns Hopkins Aramco Healthcare supports the first Applied Medical Research Forum in Dammam, bringing together healthcare leaders to shape the future of medical innovation in the Kingdom.
Cancer patients at Johns Hopkins Aramco Healthcare now have access to elranatamab, a new immunotherapy that gives hope to multiple myeloma patients who haven't responded to other treatments.